Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Prepaid Assets (2020 - 2025)

Ovid Therapeutics (OVID) has disclosed Prepaid Assets for 6 consecutive years, with $3.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Prepaid Assets rose 3.4% year-over-year to $3.2 million, compared with a TTM value of $3.2 million through Sep 2025, up 3.4%, and an annual FY2024 reading of $2.9 million, down 23.86% over the prior year.
  • Prepaid Assets was $3.2 million for Q3 2025 at Ovid Therapeutics, down from $3.7 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $5.7 million in Q2 2023 and bottomed at $1.8 million in Q1 2023.
  • Average Prepaid Assets over 5 years is $3.2 million, with a median of $2.9 million recorded in 2025.
  • The sharpest move saw Prepaid Assets surged 108.22% in 2023, then crashed 32.89% in 2024.
  • Year by year, Prepaid Assets stood at $2.7 million in 2021, then decreased by 11.27% to $2.4 million in 2022, then soared by 58.16% to $3.8 million in 2023, then dropped by 23.86% to $2.9 million in 2024, then increased by 12.43% to $3.2 million in 2025.
  • Business Quant data shows Prepaid Assets for OVID at $3.2 million in Q3 2025, $3.7 million in Q2 2025, and $2.9 million in Q1 2025.